238 related articles for article (PubMed ID: 11562667)
1. Allergic reactions to isosulfan blue during sentinel node biopsy--a common event.
Cimmino VM; Brown AC; Szocik JF; Pass HA; Moline S; De SK; Domino EF
Surgery; 2001 Sep; 130(3):439-42. PubMed ID: 11562667
[TBL] [Abstract][Full Text] [Related]
2. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.
King TA; Fey JV; Van Zee KJ; Heerdt AS; Gemignani ML; Port ER; Sclafani L; Sacchini V; Petrek JA; Cody HS; Borgen PI; Montgomery LL
Ann Surg Oncol; 2004 May; 11(5):535-41. PubMed ID: 15123464
[TBL] [Abstract][Full Text] [Related]
3. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
Raut CP; Hunt KK; Akins JS; Daley MD; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
Cancer; 2005 Aug; 104(4):692-9. PubMed ID: 15981283
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma.
Leong SP; Donegan E; Heffernon W; Dean S; Katz JA
Ann Surg Oncol; 2000 Jun; 7(5):361-6. PubMed ID: 10864344
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Thevarajah S; Huston TL; Simmons RM
Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
[TBL] [Abstract][Full Text] [Related]
6. Allergic reactions to isosulfan blue in sentinel lymph node mapping.
Komenaka IK; Bauer VP; Schnabel FR; Horowitz E; Joseph KA; Ditkoff BA; El-Tamer MB
Breast J; 2005; 11(1):70-2. PubMed ID: 15647083
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms.
Amr D; Broderick-Villa G; Haigh PI; Guenther JM; DiFronzo LA
Am Surg; 2005 Sep; 71(9):720-4. PubMed ID: 16468505
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
9. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.
Montgomery LL; Thorne AC; Van Zee KJ; Fey J; Heerdt AS; Gemignani M; Port E; Petrek J; Cody HS; Borgen PI
Anesth Analg; 2002 Aug; 95(2):385-8, table of contents. PubMed ID: 12145056
[TBL] [Abstract][Full Text] [Related]
10. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping.
Kaufman G; Guth AA; Pachter HL; Roses DF
Am Surg; 2008 Feb; 74(2):152-5. PubMed ID: 18306869
[TBL] [Abstract][Full Text] [Related]
11. Anaphylaxis to isosulfan blue.
Laurie SA; Khan DA; Gruchalla RS; Peters G
Ann Allergy Asthma Immunol; 2002 Jan; 88(1):64-6. PubMed ID: 11814281
[TBL] [Abstract][Full Text] [Related]
12. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis to isosulfan blue dye during sentinel lymph node biopsy.
Sandhu S; Farag E; Argalious M
J Clin Anesth; 2005 Dec; 17(8):633-5. PubMed ID: 16427538
[TBL] [Abstract][Full Text] [Related]
15. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
16. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
[TBL] [Abstract][Full Text] [Related]
17. Adverse events associated with the intraoperative injection of isosulfan blue.
Daley MD; Norman PH; Leak JA; Nguyen DT; Bui TP; Kowalski AM; Srejic U; Popat K; Arens JF; Gershenwald JE; Hunt KK; Kuerer HM
J Clin Anesth; 2004 Aug; 16(5):332-41. PubMed ID: 15374553
[TBL] [Abstract][Full Text] [Related]
18. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.
Albo D; Wayne JD; Hunt KK; Rahlfs TF; Singletary SE; Ames FC; Feig BW; Ross MI; Kuerer HM
Am J Surg; 2001 Oct; 182(4):393-8. PubMed ID: 11720678
[TBL] [Abstract][Full Text] [Related]
19. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
Raut CP; Daley MD; Hunt KK; Akins J; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
J Clin Oncol; 2004 Feb; 22(3):567-8. PubMed ID: 14752082
[No Abstract] [Full Text] [Related]
20. [Anaphylactic reaction to patent blue in sentinel node biopsy].
Galatius H; Holtveg HM; Følsgård SL
Ugeskr Laeger; 2003 Aug; 165(34):3242-3. PubMed ID: 12970997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
